Rocky Mountain Cancer Centers

What Rocky Mountain Cancer Centers does

Rocky Mountain Cancer Centers (RMCC) is the largest multidisciplinary oncology and hematology practice in Colorado, providing comprehensive cancer and blood disorder care through four outpatient treatment centers spanning the Colorado Front Range (Denver, Boulder, Colorado Springs, and Pueblo). The practice operates as a private, provider-based clinical services organization and is affiliated with The US Oncology Network, a large national network of community-based oncology practices. Patient volume is acquired through physician referrals, self-referrals, second opinion requests, and direct appointment scheduling, with target populations including adult cancer patients, blood disorder patients, at-risk individuals seeking genetic screening, and survivors requiring long-term follow-up care.

The clinical service portfolio spans the full oncology care continuum, including chemotherapy, radiation therapy (external beam and HDR brachytherapy), immunotherapy, hormone therapy, targeted therapy, radiopharmaceutical therapy (notably PSMA/Pluvicto for metastatic castration-resistant prostate cancer), bispecific antibody therapy, and surgical oncology. Supporting services include diagnostic imaging (3D mammography, MRI, CT), on-site laboratory and specialty pharmacy, genetic counseling and BRCA testing, clinical trial enrollment, palliative and supportive care, telehealth, and a patient portal. The underlying technology stack is predominantly clinical rather than proprietary software; advanced treatment modalities such as PSMA PET imaging, robotic laparoscopic surgery, and scalp cooling require specialized equipment and trained personnel but are not unique to RMCC.

RMCC generates revenue through insurance-based billing across private insurance, Medicare, and Medicaid, with secondary revenue from clinical trial participation and diagnostic/imaging services. A financial counseling program supports uninsured and underinsured patients. The practice positions itself on multidisciplinary care integration, advanced modality adoption, and convenient geographic access across Colorado's Front Range, with sub-brand specialization in breast cancer (Rocky Mountain Breast Specialists). No public revenue, headcount, or ownership figures are disclosed; the practice operates as part of The US Oncology Network's strategic network structure.

Name

Rocky Mountain Cancer Centers

Legal name

Rocky Mountain Cancer Centers

Website

https://rockymountaincancercenters.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

251–500 employees

Short description

Rocky Mountain Cancer Centers is the largest multidisciplinary oncology and hematology practice in Colorado, operating four outpatient treatment centers across the Front Range (Denver, Boulder, Colorado Springs, Pueblo) and affiliated with The US Oncology Network. It serves adult cancer patients, blood disorder patients, and at-risk individuals through chemotherapy, radiation therapy, immunotherapy, surgery, clinical trials, and supportive care services.

Ownership category

akta.pro rank

Headquarters

HQ city

Greenwood Village

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Patient Care Services: Direct revenue from providing comprehensive cancer treatment services including chemotherapy, radiation therapy, immunotherapy, targeted therapy, hormone therapy, surgery, and supportive care. Billed through insurance plans, Medicare, Medicaid, and patient payments.
2. Clinical Trial Services: Revenue from participation in clinical trials, which may include compensation for research activities and drug administration as part of study protocols.
3. Diagnostic and Imaging Services: Revenue from diagnostic imaging, laboratory services, biomarker testing, pathology services, and genetic testing conducted at their facilities.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Rocky Mountain Cancer Centers is a multidisciplinary outpatient oncology practice that provides comprehensive cancer and blood disorder care, including chemotherapy, radiation therapy, immunotherapy, targeted therapy, hormone therapy, radiopharmaceutical therapy, surgery, diagnostic imaging, genetic testing, pharmacy, laboratory, and supportive care services. Treatment is delivered through multiple Front Range locations to adult cancer patients across Colorado.

Product overview

Rocky Mountain Cancer Centers is the largest multidisciplinary oncology practice in Colorado dedicated solely to cancer and blood disorder care. The organization provides a comprehensive suite of treatment services including chemotherapy, radiation therapy, immunotherapy, hormone therapy, targeted therapy, radiopharmaceutical therapy, and bispecific cancer therapy. They offer integrated support services such as diagnostic imaging, on-site pharmacy, laboratory services, genetic counseling and testing, clinical trials, telehealth appointments, and supportive care. The practice specializes in treating over 20 cancer types including breast, lung, colorectal, prostate, lymphoma, leukemia, gynecologic, and thyroid cancers. Patient-facing digital services include an online patient portal for accessing medical records and managing care.

Differentiator

Problem solved

Functional benefit

Brands

• Rocky Mountain Breast Specialists: Specialized breast cancer care division of Rocky Mountain Cancer Centers

Products and services

• Chemotherapy Treatment Drug therapy that uses chemicals to kill cancer cells or stop them from dividing, administered via various routes including IV infusion, for adult cancer patients.
• Radiation Therapy High-energy radiation therapy using external beam or internal implants (brachytherapy) to destroy cancer cells in adult cancer patients.
• Immunotherapy Treatment that uses the body's immune system to fight cancer by stimulating or restoring immune function for adult oncology patients.
• Targeted Therapy Drugs that target specific genes, proteins, or pathways involved in cancer growth and survival, used for adult cancer patients.
• Hormone Therapy Treatment that removes or blocks hormones to stop cancer growth, particularly for breast and prostate cancer patients.
• Radiopharmaceutical Therapy Internal radiation therapy using radioactive drugs that target and destroy cancer cells, including PSMA therapy for metastatic prostate cancer patients.
• Bispecific Cancer Therapy Treatment using bispecific antibodies that bind to two different targets simultaneously to attack cancer cells in adult oncology patients.
• PSMA Therapy (Pluvicto/Pylarify) Advanced prostate cancer treatment combining PSMA PET imaging (Pylarify) with targeted radioactive therapy (Pluvicto) for metastatic castration-resistant prostate cancer patients.
• Diagnostic Imaging Advanced imaging services including mammography, ultrasound, MRI, and CT scans for cancer detection, staging, and treatment monitoring.
• Pharmacy Services On-site and specialty pharmacy services for cancer medications and chemotherapy drugs provided to oncology patients.
• Laboratory Services On-site laboratory testing for cancer diagnosis, monitoring, and treatment management for oncology patients.
• Genetic Counseling and Testing Genetic risk assessment and testing services including BRCA gene testing and hereditary cancer syndrome evaluation for at-risk individuals and cancer patients.
• Clinical Trials Access to clinical research studies and experimental treatments through partnerships for cutting-edge cancer care for adult oncology patients.
• Telehealth Appointments Virtual healthcare appointments allowing remote consultations with oncology specialists for cancer patients and at-risk individuals.
• Supportive Care Palliative and supportive care services including pain management, nutrition counseling, and mental health support for cancer patients and survivors.
• Breast Cancer Care Comprehensive breast cancer diagnosis, treatment, and survivorship care including surgery, reconstruction, and genomic testing for breast cancer patients.
• Lung Cancer Care Complete lung cancer care including biomarker testing, staging, and personalized treatment options for lung cancer patients.
• Colorectal Cancer Care Colon and rectal cancer treatment including surgery, chemotherapy, and staging services for colorectal cancer patients.
• Prostate Cancer Care Comprehensive prostate cancer treatment including radiation therapy, hormone therapy, PSMA therapy, and active surveillance for prostate cancer patients.
• Lymphoma Care Treatment for Hodgkin and non-Hodgkin lymphomas including chemotherapy and targeted therapies for lymphoma patients.
• Leukemia Care Blood cancer treatment including various types of leukemia with chemotherapy and clinical trials for leukemia patients.
• Gynecologic Cancer Care Treatment for cervical, ovarian, uterine, and other gynecologic cancers including surgery for gynecologic cancer patients.
• Thyroid Cancer Care Treatment for various types of thyroid cancer including papillary, follicular, medullary, and anaplastic thyroid cancer for thyroid cancer patients.
• Patient Portal Online patient portal for accessing medical records, requesting prescription refills, and communicating with care team, available to oncology patients.

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

One partnership is on record.

• The US Oncology NetworkcoreStrategic or Co-development PartnerRocky Mountain Cancer Centers is affiliated with The US Oncology Network, one of the nation's largest networks of community-based oncology practices. This affiliation provides access to shared clinical resources, best practices, research collaboration, and clinical trial opportunities across hundreds of oncology providers nationwide.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Others

• McKesson / US Oncology Network: Parent network providing RMCC with operational infrastructure, group purchasing, clinical research, and payor contracting; an ecosystem enabler and strategic parent rather than a direct competitor.
• Flatiron Health: Oncology-focused health technology and real-world data provider used by US Oncology Network practices for EHR and research enablement; an enabling ecosystem participant adjacent to RMCC's clinical operations.

Broad incumbents

• City of Hope: NCI-designated comprehensive cancer center with national clinical network and community oncology sites; a broader incumbent that has absorbed community oncology platforms and competes for complex cases and research.
• Memorial Sloan Kettering Cancer Center: National NCI-designated cancer center that competes for complex and second-opinion cases out-of-state; relevant as the gold-standard incumbent for advanced oncology treatment and clinical research.
• UCHealth University of Colorado Hospital: Denver-based academic medical center with NCI-designated cancer program; competes for the most complex cancer cases in RMCC's primary Front Range market as a broader, hospital-based incumbent.

Direct peers

• 21st Century Oncology: Large community-based radiation oncology and integrated cancer care provider with multi-state outpatient centers; directly comparable in radiation therapy delivery, brachytherapy, and multidisciplinary oncology services.
• Sarah Cannon Cancer Institute: Hospital-affiliated community oncology network providing multidisciplinary cancer care and clinical research across multiple states; competes for community oncology referrals and trial enrollment in overlapping ways.
• Texas Oncology: Largest member practice of The US Oncology Network and the most direct operational peer to RMCC; provides the same multidisciplinary community oncology model across Texas with infusion, radiation, imaging, and clinical trials.
• Arizona Oncology: Another US Oncology Network member practice operating community-based multidisciplinary oncology services, comparable in scale and service mix to RMCC but in a different state geography.
• Compass Oncology: US Oncology Network-affiliated community oncology practice in the Pacific Northwest offering comprehensive medical, radiation, and surgical oncology with clinical trial access — directly comparable in operating model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/rocky-mountain-cancer-centers

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rocky Mountain Cancer Centers